The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia  by Eslami, Mohammad H. et al.
From the New England Society for Vascular Surgery
The adverse effects of race, insurance status, and
low income on the rate of amputation in patients
presenting with lower extremity ischemia
Mohammad H. Eslami, MD,a Maksim Zayaruzny, MD,b and Gordon A. Fitzgerald, PhD,b
Worcester, Mass
Objectives: A consequence of delay in the diagnosis of peripheral vascular disease limb loss. This study was undertaken to
determine the correlation of low socioeconomic status and race on the severity of ischemic presentation and the
subsequent amputation rate.
Methods:Data from the Nationwide Inpatient Sample (NIS) from 1998 to 2002 on patients from urban hospitals with the
diagnosis of lower extremity ischemia were evaluated. The population was divided into two groups: the amputation group
(AMP) and lower extremity revascularization group (LER). Comorbidities, age, gender, race, ischemic gangrene at
presentation, insurance status (no/noncommercial or commercial), and income status at admission were determined.
These variables were compared using multivariate logistic regression analyses of the data for risk adjustment.
Results:Of 691,833 patients presenting with lower extremity ischemia, 363,193 underwent revascularization (66.3%) or
amputation (33.7%). Univariate analysis correlated a statistically significant (P < .0001) higher rate of amputation and
multivariate analysis associated significantly higher odds of amputation with the following variables: nonwhites (1.91,
95% confidence interval [CI], 1.65, 2.20), low-income bracket (1.41, 95% CI, 1.18, 1.60), and Medicare & Medicaid
(1.81, 95% CI, 1.66, 1.97). Adjusting for other variables of statistical significance, multivariate regression analysis
showed a statistically significant risk for amputation based on the nonteaching status of the institution (odds ratio [OR],
1.17, 95% CI, 1.08, 1.30).
Conclusions: Primary amputation was performed with a higher frequency on patients with lower extremity ischemia who
were nonwhite, low income, and without commercial insurance. The observed advanced ischemia among these econom-
ically disadvantaged patients suggests a delayed diagnosis of peripheral vascular disease, probably due to lack of access to
adequate primary care or vascular surgery providers, or both. Better education of the general population and primary care
providers to the symptoms and consequences of PVD may reduce the amputation rate in this group. (J Vasc Surg 2007;
45:55-9.)Late presentation and delay in diagnosis and treatment
of peripheral vascular disease (PVD) may lead to limb loss.
In addition to the immense psychologic toll of amputation,
the yearly cost of providing care to amputees is estimated at
$4.3 billion.1 Furthermore, 25% to 60% of amputees never
ambulate with a prosthesis and another 30% have reampu-
tation or die 12 months of the initial procedure.1 Despite
many advances in the fields of vascular and endovascular
surgery during the past decade, an alarming increase in the
number of amputations has been reported.2
Studies evaluating disparities of amputation rates
among PVD patients with different sociodemographic vari-
ables have shown continuous differences in the per capita
rate of amputation among different races,3-7 income lev-
els,6,8 and gender.4 Some of the racial disparities can be
attributed to the higher prevalence of diabetes9 or difficult-
to-control diabetes among nonwhite patients,10-13 or to
racial differences in the severity and characteristics of PVD
From the Division of Vascular Surgery,a University of Massachusetts Med-
ical School, and Center for Outcomes Research.b
Competition of interest: none.
Reprint requests: Mohammad H. Eslami, MD, FACS, Division of Vascular
Surgery, University of Massachusetts Medical School, 55 N. Lake Ave,
Worcester, MA 01655 (e-mail: eslamim@ummhc.org).
0741-5214/$32.00
Copyright © 2007 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2006.09.044at the time of presentation to a vascular surgeon.14-18
However, there is no evidence to suggest that inherent
genetic differences between races or ethnicities can account
for disparities of outcome such as limb salvage vs revascu-
larization.19
Rather, many studies have shown that a decrease in
amputation rates is possible with appropriate primary care,
timely referral to vascular surgical centers, adequate foot
and wound care, and aggressive limb arterial revasculariza-
tion therapies, regardless of the presence of cormorbid-
ites.20-25 Reported inconsistencies in amputation rates
therefore suggest that barriers to appropriate, effective, and
timely care exist across the racial and sociodemographic
spectrum. The purpose of this study was to determine how
income level, insurance status, and race correlate with
amputation rates in patients with lower extremity ischemia
who present to urban hospitals.
METHODS
Data source. The Nationwide Inpatient Sample (NIS),
a stratified, cross-sectional database resulting from a fed-
eral, state, and private industry partnership, includes ap-
proximately 20% of all nonfederal hospital discharges in the
United States.26 The database, which includes information
on 100% of discharges at participating hospitals, is stratified
by geographic region, urban or rural hospital location,
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hospital size. Data for this study were derived from the NIS
database from 1998 to 2002, inclusive.
The databases were searched initially to identify all
inpatient admissions for which the primary International
Classification of Diseases, Ninth Revision, Clinical Modifi-
cation (ICD-9-CM) indicated a diagnosis code for periph-
eral vascular disease (443.9), atherosclerosis, and lower
extremity ischemia with or without gangrene (440.20, 21,
23, 24; 440-30, 31, 32). Patients presenting with traumatic
ischemia or arterial embolism were excluded. To minimize
the potential for bias owing to coding variations among the
participating hospitals and to address the possibility of
overlap between groups, 13 distinct codes were used to
identify patients.
To assess the effect of race, the study was limited to urban
hospitals, which generally have a more racially diverse patient
population than rural settings (www.census.org).
Patients were divided into two groups by operative
procedure. The first group included patients with primary
ICD-9-CM procedure codes for lower extremity amputa-
tion (84.1, 84.10, 15-19) (AMP). Patients with toe ampu-
tations or partial foot or ankle amputations were excluded.
The second group included those with a lower extremity
revascularization (39.25, 39.29) (LER). Patients who had
both procedures—revascularization and amputation—at
the index admission were also excluded from this analysis.
Statistical analysis. All statistical analyses were per-
formed using SAS 9.2 (SAS Institute, Cary, NC) software.
Because the NIS databases are stratified probability samples
of US community hospitals, calculations were adjusted
to reflect the survey sampling characteristics (probability
weights, cluster sampling, and stratification). Probability
weights were provided for each record in the NIS database.
Stratification was performed for geographic region, teach-
ing status, ownership, and hospital size; hospitals were used
as cluster units.
Factors such as hospital type, initial presentation, comor-
bidities, age, gender, race, income status, and insurance payer
mix were compared among the two procedure groups. Race
was identified as a dichotomous variable: white vs nonwhite.
Univariate analyses, using 2 testing, were performed to
compare theses variables among groups during the index
admission, and statistically significant variables (P  .05)
were analyzed further. The elimination multiple logistic
regression analyses of statistically significant variables—
controlling and adjusting risk across each study population—
were performed, and (odds ratios [ORs], 1.17, 95% CI, 1.08,
1.30) were generated.
RESULTS
According to NIS data, 691,833 patients presented
with the primary diagnosis of lower extremity ischemia or
gangrene to urban hospitals during the study period. Of
these 363,193 underwent either lower extremity revascu-
larization (240,740; 66.3%) or amputation (122,453;
33.7%) as the primary procedure during the index admis-
sion. Selected comorbidities are summarized in Table I.The average patient age was 70.6 years, with a statistically
significant difference (P  .0001) in the mean ages of the
LER (68.9, 95%) and AMP (73.2, 95%) groups. Although
most patients were men (54.6%), more AMP patients were
women (49% vs 43.9%, P  .001); conversely, more men
were in the LER group (57% vs 51%, P  .001). Diabetes
and chronic renal failure were more common among the
AMP group, and chronic obstructive pulmonary disease,
hypertension, and coronary artery disease were more com-
mon in the LER group.
The racial composition of the groups is also summa-
rized in Table I. At 80.0%, the LER group included a
significantly higher percentage of white patients (P .001)
compared with the general population (74.1%) and the
AMP (61.2%) group. Conversely, nonwhite patients were
more prominently represented in the AMP group (38.8% vs
25.9% and 20% for LER; P  .001). Initial ischemic pre-
sentation significantly differed among the two procedure
groups, as a significantly higher percentage of AMP pa-
tients (76.4%) presented with ischemic gangrene compared
with the LER group (15.6%, P  .001).
More than half of the patients (53.6%) were treated at
teaching hospitals, and 60.1% underwent revascularization.
The reverse was true at nonteaching hospitals, where am-
putation rates were statistically significantly higher (45.2%
vs 39.9%, P  .0001). Adjusting for other variables of
statistical significance, multivariate regression analysis for
OR estimates showed a statistically significant risk (OR 
1.17, 95% CI, 1.08, 1.30) for amputation based on the
nonteaching status of the institution where patients were
Table I. Nationwide Inpatient Sample data (1998-2000)
for patients presenting to urban hospitals with the
diagnosis of lower extremity ischemia who subsequently
had a procedure
Characteristics
Overall*
(%)
Amputation*
(%)
Vascularization*
(%)
Weighted
frequency (n) 363,193 122,453 240,740
Average age (year) 70.6 74.5* 68.9*
Female sex 45.4 49.7* 43*
Race
White 74.1* 61.2* 80*
Nonwhite 25.9* 38.8* 20*
Diabetes 42.1 49.7* 38.9*
CRF 2.7 4.8* 1.7*
Hypertension 50.3 40.7* 54.3*
CHD 10.8 9.3* 11.5*
COPD 1.8 1.1* 2.2*
Ischem w/o
gangrene 66.3 23.6* 84.3*
Ischemic gangrene 37.2 76.4* 15.6*
Hospital type
Teaching 53.8 39.9* 60.1*
Nonteaching 46.2 45.2* 54.8*
CRF, Chronic renal failure; CHD, chronic heart disease; COPD, chronic
obstructive pulmonary disease.
*P  .001.cared for (Table II).
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insurance payer mix were also found to be significantly
different between the AMP and LER groups (Fig 1). The
NIS-reported median income of each patient’s postal ZIP
code was used as a proxy for socioeconomic status to divide
the patient population was into three economic groups. Of
these, 36.1% were in the highest income group ($45,000/
year), and 8% were in the lowest ($24,999/year). The LER
group, however, contained fewer patients from the lowest
income category (6.5%) compared with the AMP group
(10.6%), a statistically significant difference (P  .0001).
The two procedure subgroups also had disparate pri-
mary payer compositions. Among this patient population,
Medicare was the most common provider (71.2%), and the
second most common was a combination of private insur-
ance orHealthMaintenanceOrganization (private/HMO,
21.4%). Medicaid beneficiaries were 5.8% of the group; the
remaining 1.6% was excluded because no insurance type
Table II. Multiple logistic regression analysis results for
amputation vs. lower extremity revascularization using
Nationwide Inpatient Sample data, 1998-2000
Sociodemographic factors OR 95% Wald CL
Age 70 1.43 1.13, 1.55
Female 1.139 1.02, 1.11
Nonwhite 1.90 1.75, 2.05
Diabetes 1.15 1.09, 1.22
CRF 1.39 1.19, 1.64
Hypertension 0.67 0.63, 0.68
COPD 0.61 0.52, 0.71
Ischemic gangrene 15.04 12.14, 14.32
Income ZIP*
$24,999 1.41 1.18, 1.60
$25,000-$34,999 1.22 1.10, 1.36
$35,000-$44,999 1.15 1.01, 1.27
Medicaid 1.91 1.65, 2.20
Medicare 1.81 1.66, 1.97
OR, Odds ratio; CL, confidence limits; CRF, chronic renal failure; COPD,
chronic obstructive pulmonary disease.
*Patient’s postal ZIP code was used as a proxy for socioeconomic status.
Fig 1. Rate of amputation (AMP) or lower extremity revascular-
ization (LER) compared among different socioeconomic vari-
ables.was documented. Notably, the AMP group included 82.2%Medicare patients and 10.6% private/HMO patients, and
the LER group had 66.4% Medicare and 26% private/
HMO patients. Univariate analysis showed a statistically
significant association between the procedure performed
during the index admission and the primary payer (P 
.0001). Similarly, Medicare recipients had the highest rate
of amputation and lowest rate of revascularization (34.1%
AMP, 65.1% LER) compared with Medicaid (31%, 68.9%)
and private/HMO beneficiaries (14.8%, 85.2%; Fig 1).
Table II summarizes the multiple logistic regression
analyses data. Independently, age 70, female sex, diabe-
tes, chronic renal failure, hospital type, and ischemic gangrene
were found to significantly increase the risk of undergoing
amputation. Initial presentation of ischemic gangrene was the
most important determinant, increasing the odds of having an
amputation 15-fold. This analysis, which controls for the
simultaneous effect of diabetes, gangrene, and chronic renal
failure, indicates that the race and socioeconomic factors
evaluated here (income and payer mix) independently in-
crease the risk of having amputation. Low-income patients
have a 1.41-fold risk of having an amputation compared
with high-income patients (OR, 1.41, 95% CI, 1.18, 1.60).
This odds ratio gradually decreases as patient income in-
creases (Table II).
Compared with private/HMO patients, both Medic-
aid (1.9-fold) and Medicare (1.8-fold) patients were more
likely to have amputations (Table II); among the latter two,
Medicaid patients have the highest OR for amputation than
Medicare recipients (P .001). AlthoughMedicare patient
age (74.6 years) was significantly higher (P  .001) than
Medicaid (59.2 years) and private/HMO patients (61.3
years), the Medicaid patients had the highest OR for am-
putation (P  .001).
Fig 2 shows that diabetes, an independent predictor of
amputation, was more common among nonwhites (53.1%
vs 37.1%, P  .001), Medicaid (45.9% vs 39.4% [private],
or 44.4% [Medicare], P  .001 and P  .05, respectively),
Fig 2. Rate of diabetes among different socioeconomic vari-
ables.and the lowest-income group (P .001). The diabetes rate
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(50.7% vs 33%, P .001) and low-income patients (46.3%
vs 36.9%, P  .001) presented more commonly with isch-
emic gangrene, as did Medicaid patients compared with
Medicare recipients (50.7% vs 23%, P  .001).
DISCUSSION
The purpose of this study, which examined data col-
lected in urban hospitals from 1998 to 2002, was to deter-
mine the correlation of low socioeconomic status and race
on the severity of ischemic presentation and subsequent
amputation rate in patients presenting with lower extremity
ischemia. Comorbidities, including diabetes, chronic renal
failure, and gangrene, were significantly associated with
amputation. Age, gender, income level, and insurance sta-
tus also were found to independently affect amputation
rates.
Age as a risk factor for amputation may be due to the
prevalence of PVD in older patients, reported by Selvin and
Erlinger27 to increase from 7% in adults younger than age
70 to14.5% in older adults. Increased amputation risk for
women, also reported previously6, may reflect the inclusion
of more women in this older, PVD-susceptible group.
Underprivileged patients in this study, such as nonwhites,
low-income, or Medicaid recipients, presented more com-
monly with diabetes, chronic renal failure, or gangrene, as
reported previously.3,6,7,9,12,13,19,21,28 The observed ad-
vanced ischemia among these economically disadvantaged
patients suggests a delayed diagnosis of PVD, probably
owing to lack of access to adequate primary care or vascular
surgery providers, or both, as well cultural distrust.30-32
Better education of the general population, particularly
minorities, and primary care providers on the symptoms
and consequences of PVD may reduce the amputation rate
in this group.
Medicare andMedicaid patients exhibited a higher rate
of amputation compared with patients with private insur-
Fig 3. Initial presentation of ischemia with or without gangrene
among different socioeconomic variables.ance. Age and diabetes in these two groups may partlyaccount for this trend, but delayed presentation appears to
play a significant role, especially among Medicaid patients,
who often receive care in the emergency department.33
Several shortcomings of this study stem from errors
inherent in using NIS data, including coding errors,34
changes in sampling and weighting strategies owing to an
expansion in the number of participating sites during the
study, administrative errors resulting from changes in ICD-9
codes (partially addressed by using 13 different codes), and
missing data on racial makeup. In addition, the inability to
track prior or subsequent hospitalization/revascularization of
individual patients may affect the findings because a single
patient may at different time points be a member of one or
another group. From that perspective, the study as designed
provides a snapshot of the NIS database, which can be used
to draw conclusions about population tendencies. The
results obtained here are consistent with previous reports
using different methodology and databases,3,6,7 suggesting
that they accurately reflect the overall picture.
CONCLUSION
The data suggest there is a disparity of care provided
to patients with PVD on the basis of race, income, and
insurance status. Unlike more affluent white patients
who undergo revascularization, those who are nonwhite,
poor, and Medicaid recipients are more likely to undergo
amputation. The elimination of barriers to appropriate
medical care along with better education of the conse-
quences of diabetes and the signs and symptoms of PVD
may lead to earlier presentation and significantly de-
crease amputation rates.29
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